Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2018 | New developments for improving the QoL in survivorship

Andrew Bottomley • 14 Nov 2018
NCRI 2018
General

In this interview, Andrew Bottomley, PhD, from the European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium, discusses survivorship as an increasingly important priority, before revealing a series of new measures which aim to assess it. Speaking at the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK, Dr Bottomley introduces the exciting new developments at EORTC, providing patients with helpful information and resources for improved survivorship.

More from Andrew Bottomley

1:33
Survivorship: the previously underfunded area in cancer research
Andrew Bottomley • 15 Nov 2018
1:35
The changing landscape of survivorship: giving the patient a voice
Andrew Bottomley • 15 Nov 2018

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals